Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.
2.

Dose-volume histogram predictors of chronic gastrointestinal complications after radical hysterectomy and postoperative concurrent nedaplatin-based chemoradiation therapy for early-stage cervical cancer.

Isohashi F, Yoshioka Y, Mabuchi S, Konishi K, Koizumi M, Takahashi Y, Ogata T, Maruoka S, Kimura T, Ogawa K.

Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):728-34. doi: 10.1016/j.ijrobp.2012.05.021. Epub 2012 Jun 23.

PMID:
22727885
3.
4.

Predictors of grade 3 or higher late bowel toxicity in patients undergoing pelvic radiation for cervical cancer: results from a prospective study.

Chopra S, Dora T, Chinnachamy AN, Thomas B, Kannan S, Engineer R, Mahantshetty U, Phurailatpam R, Paul SN, Shrivastava SK.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):630-5. doi: 10.1016/j.ijrobp.2013.11.214.

PMID:
24521678
5.

The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer.

Baglan KL, Frazier RC, Yan D, Huang RR, Martinez AA, Robertson JM.

Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):176-83.

PMID:
11777636
6.
7.

A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.

Myerson RJ, Valentini V, Birnbaum EH, Cellini N, Coco C, Fleshman JW, Gambacorta MA, Genovesi D, Kodner IJ, Picus J, Ratkin GA, Read TE.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1299-308.

PMID:
11483342
8.

Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model.

Robertson JM, Söhn M, Yan D.

Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):66-72. doi: 10.1016/j.ijrobp.2009.04.048. Epub 2009 Aug 6.

PMID:
19665323
9.

Predictors of late bowel toxicity using three different methods of contouring in patients undergoing post-operative radiation for cervical cancer.

Chopra S, Krishnatry R, Dora T, Kannan S, Thomas B, Sonawone S, Engineer R, Paul S, Phurailatpam R, Mahantshetty U, Shrivastava S.

Br J Radiol. 2015;88(1055):20150054. doi: 10.1259/bjr.20150054. Epub 2015 Sep 22.

10.

Acute small bowel toxicity and preoperative chemoradiotherapy for rectal cancer: investigating dose-volume relationships and role for inverse planning.

Tho LM, Glegg M, Paterson J, Yap C, MacLeod A, McCabe M, McDonald AC.

Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):505-13. Epub 2006 Jul 31.

PMID:
16879928
11.
12.

Analysis of dosimetric parameters associated with acute gastrointestinal toxicity and upper gastrointestinal bleeding in locally advanced pancreatic cancer patients treated with gemcitabine-based concurrent chemoradiotherapy.

Nakamura A, Shibuya K, Matsuo Y, Nakamura M, Shiinoki T, Mizowaki T, Hiraoka M.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):369-75. doi: 10.1016/j.ijrobp.2011.12.026. Epub 2012 Feb 28.

PMID:
22381898
13.

Dose--volume effects on patient-reported acute gastrointestinal symptoms during chemoradiation therapy for rectal cancer.

Chen RC, Mamon HJ, Ancukiewicz M, Killoran JH, Crowley EM, Blaszkowsky LS, Wo JY, Ryan DP, Hong TS.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e513-7. doi: 10.1016/j.ijrobp.2012.01.013. Epub 2012 Mar 19.

PMID:
22436781
14.

Acute toxicity of radiochemotherapy in rectal cancer patients: a risk particularly for carriers of the TGFB1 Pro25 variant.

Schirmer MA, Mergler CP, Rave-Fränk M, Herrmann MK, Hennies S, Gaedcke J, Conradi LC, Jo P, Beissbarth T, Hess CF, Becker H, Ghadimi M, Brockmöller J, Christiansen H, Wolff HA.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):149-57. doi: 10.1016/j.ijrobp.2011.05.063. Epub 2011 Oct 12.

PMID:
22000747
15.

Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.

Peeters ST, Hoogeman MS, Heemsbergen WD, Slot A, Tabak H, Koper PC, Lebesque JV.

Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1142-52. Epub 2005 Jun 4.

PMID:
15939547
16.
17.

Routine defunctioning stoma after chemoradiation and total mesorectal excision: a single-surgeon experience.

Lin SC, Chen PC, Lee CT, Tsai HM, Lin PC, Chen HH, Wu YH, Lin BW, Su WP, Lee JC.

World J Gastroenterol. 2013 Mar 21;19(11):1797-804. doi: 10.3748/wjg.v19.i11.1797.

18.

The dose-volume relationship of small bowel irradiation and acute grade 3 diarrhea during chemoradiotherapy for rectal cancer.

Robertson JM, Lockman D, Yan D, Wallace M.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):413-8. Epub 2007 Sep 27.

PMID:
17904305
20.

Neoadjuvant-intensified treatment for rectal cancer: time to change?

Musio D, De Felice F, Bulzonetti N, Guarnaccia R, Caiazzo R, Bangrazi C, Raffetto N, Tombolini V.

World J Gastroenterol. 2013 May 28;19(20):3052-61. doi: 10.3748/wjg.v19.i20.3052.

Supplemental Content

Support Center